The concept of using a targeting molecule labeled with a diagnostic radionuclide for using
positron emission tomography or single photon emission computed tomography imaging …

Peptide receptor radionuclide therapy (PRRT) using Lutetium-177 (177Lu) based
radiopharmaceuticals has emerged as a therapeutic area in the field of nuclear medicine …

Background The aim of this retrospective study was to compare the diagnostic accuracy of
somatostatin receptor (SSR)-PET/CT to liver MRI as reference standard in the evaluation of …

Simple Summary Positron emission tomography (PET), typically combined with computed
tomography (CT), has become a critical advanced imaging technique in oncology. With PET …

Covering: up to 2024Ribosomally synthesised and post-translationally modified peptides
(RiPPs) comprise a substantial group of peptide natural products exhibiting noteworthy …

Neuroendocrine neoplasms (NEN) are rare and heterogeneous tumors, originating mostly
from the gastro-entero-pancreatic (GEP) tract followed by the lungs. Multidisciplinary …

Neuroendocrine tumors (NETs) are rare neoplasms with a wide spectrum of clinical
behavior, from the long survival of well-differentiated NETs to the dismal prognosis of high …

Simple Summary Radioligand therapy with [177Lu] Lu-DOTA-TATE is a therapeutic option
for adult patients with somatostatin-receptor–positive gastroenteropancreatic …

Simple Summary Neuroendocrine neoplasms'(NENs) rarity and heterogeneity represent a
clinical challenge. Somatostatin receptor (SST) positron emission tomography/computed …

Introduction: The goal of this study is to compare the prognostic performance of NETPET
scores, based on gallium-68 DOTANOC (68Ga-DOTANOC) and fluorine-18 …